Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022 at 13:24 PM EDT
Acadia Pharmaceuticals Inc(NASDAQ: ACAD)stopped working on two candidates, including a one-time competitor toVertex ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.